Advertising

The Latest Pharma Jobs, News and Events

pharmiweb.com today | 20 March 2010

Teva acquires Ratiopharm

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced that it has entered into a definitive agreement to acquire ratiopharm, Germany's second largest generics producer and the sixth largest generic drug company worldwide, for an enterprise value of €3.625 billion. The transaction is subject to certain conditions including relevant regulatory approvals. On a pro forma basis, the combined company would have had 2009 revenues of $16.2 billion. Teva expects to complete the transaction by year-end 2010....

Commenting on today's transaction, Shlomo Yanai, Teva's President and Chief Executive Officer, said: "This is an important acquisition for Teva. This transaction is perfectly aligned with our long-term strategy in which Europe is an important pillar and growth driver. ratiopharm will provide us with the ideal platform to strengthen our leadership position in key European markets, most notably in Germany, as well as rapidly growing generic markets such as Spain, Italy and France."

show more

Latest Poll

Have you used Facebook to look for a job?

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feed | Blog

Advertising